Ali Al‐Janabi

429 total citations
16 papers, 200 citations indexed

About

Ali Al‐Janabi is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ali Al‐Janabi has authored 16 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 9 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Ali Al‐Janabi's work include Dermatology and Skin Diseases (9 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and Autoimmune Bullous Skin Diseases (3 papers). Ali Al‐Janabi is often cited by papers focused on Dermatology and Skin Diseases (9 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and Autoimmune Bullous Skin Diseases (3 papers). Ali Al‐Janabi collaborates with scholars based in United Kingdom, Australia and Russia. Ali Al‐Janabi's co-authors include Richard B. Warren, C.E.M. Griffiths, Zenas Z N Yiu, Amy Foulkes, Catherine Smith, K.J. Mason, Alexander Marsland, Simon Greenfield, H.J.A. Hunter and Zarif K. Jabbar‐Lopez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Investigative Dermatology and British Journal of Dermatology.

In The Last Decade

Ali Al‐Janabi

15 papers receiving 199 citations

Peers

Ali Al‐Janabi

DERMA

IMMUN

RHEUM

PFM

Hao Trong Nguyen Vietnam

Lucia Genco Italy

Arvin Ighani Canada

G. Girolomoni Italy

Chih-ho Hong Canada

Stephanie Mehlis United States

Maximilian Reinhardt Germany

Megan Mosca United States

A. Galluccio Italy

Ali Alsharqi United Kingdom

Hao Trong Nguyen Vietnam

Ali Al‐Janabi

91 ×0.7

DERMA

82 ×0.8

IMMUN

33 ×0.6

RHEUM

32 ×0.7

PFM

25 ×0.8

Citations per year, relative to Ali Al‐Janabi Ali Al‐Janabi (= 1×) peers Hao Trong Nguyen

Countries citing papers authored by Ali Al‐Janabi

Since Specialization

Citations

This map shows the geographic impact of Ali Al‐Janabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Al‐Janabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Al‐Janabi more than expected).

Fields of papers citing papers by Ali Al‐Janabi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Al‐Janabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Al‐Janabi. The network helps show where Ali Al‐Janabi may publish in the future.

Co-authorship network of co-authors of Ali Al‐Janabi

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Al‐Janabi. A scholar is included among the top collaborators of Ali Al‐Janabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Al‐Janabi. Ali Al‐Janabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Al‐Janabi, Ali, Paul Martin, Catherine Simpson, et al.. (2025). Blood Single-Cell Transcriptomic and Proteomic Signatures of Paradoxical Eczema in Patients with Psoriasis Treated with Biologics. Journal of Investigative Dermatology. 145(10). 2535–2548. 1 indexed citations

Al‐Janabi, Ali, et al.. (2025). A multidisciplinary review of long COVID to address the challenges in diagnosis and updated management guidelines. Annals of Medicine and Surgery. 87(4). 2105–2117. 1 indexed citations

Al‐Janabi, Ali, Stephen Eyre, Amy Foulkes, et al.. (2023). Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with Biologics. Journal of Investigative Dermatology. 143(8). 1470–1478.e1. 13 indexed citations

Al‐Janabi, Ali & Zenas Z N Yiu. (2022). Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management. SHILAP Revista de lepidopterología. 20 indexed citations

Asfour, Leila, et al.. (2022). Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a systematic review of alopecia areata clinical practice guidelines. Clinical and Experimental Dermatology. 48(2). 100–107. 6 indexed citations

Al‐Janabi, Ali, Amy Foulkes, C.E.M. Griffiths, & Richard B. Warren. (2022). Paradoxical eczema in patients with psoriasis receiving biologics: a case series. Clinical and Experimental Dermatology. 47(6). 1174–1178. 9 indexed citations

Al‐Janabi, Ali, Amy Foulkes, H.J.A. Hunter, et al.. (2022). The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study. British Journal of Dermatology. 188(4). 542–551. 2 indexed citations

Al‐Janabi, Ali, B.W.M. Arents, Leila Asfour, et al.. (2021). Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a scoping review of dermatology clinical practice guidelines*. British Journal of Dermatology. 185(4). 736–744. 17 indexed citations

Al‐Janabi, Ali, et al.. (2021). Bimekizumab: a dual IL-17A and IL-17F inhibitor for the treatment of psoriasis and psoriatic arthritis. Expert Review of Clinical Immunology. 17(10). 1073–1081. 11 indexed citations

10.

Al‐Janabi, Ali & Alexander Marsland. (2020). Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports. SHILAP Revista de lepidopterología. 8(8). 1458–1460. 18 indexed citations

11.

Al‐Janabi, Ali, et al.. (2020). Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre. Dermatology and Therapy. 11(1). 149–160. 16 indexed citations

12.

Al‐Janabi, Ali & Richard B. Warren. (2020). Update on risankizumab for the treatment of moderate to severe psoriasis. Expert Opinion on Biological Therapy. 20(11). 1245–1251. 6 indexed citations

13.

Al‐Janabi, Ali & Richard B. Warren. (2020). Risankizumab vs. adalimumab for moderate‐to‐severe plaque psoriasis: a critical appraisal. British Journal of Dermatology. 183(2). 220–221.

14.

Al‐Janabi, Ali, Amy Foulkes, K.J. Mason, et al.. (2020). Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review. Journal of the European Academy of Dermatology and Venereology. 34(7). 1440–1448. 61 indexed citations

15.

Al‐Janabi, Ali, Zarif K. Jabbar‐Lopez, C.E.M. Griffiths, & Zenas Z N Yiu. (2019). Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal. British Journal of Dermatology. 180(6). 1348–1351. 9 indexed citations

16.

Al‐Janabi, Ali & Simon Greenfield. (2015). Pemphigus vulgaris: a rare cause of dysphagia. BMJ Case Reports. 2015. bcr2015212661–bcr2015212661. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact